Patients who got Eli Lilly and Co's anti-clotting drug prasugrel after a coronary stent conduct had fewer stent-related clots than those on standard drug therapy, an analysis released on cheap handgun found.
More: - Brought to my attention by
Name(required)
Mail (will not be published)(required)
Website
Notify me of followup comments via e-mail.